Literature DB >> 7733541

The role of preoperative localization in primary hyperparathyroidism.

E C Lundgren1, A R Gillott, J S Wiseman, J Beck.   

Abstract

Hyperparathyroidism is being increasingly recognized by the detection of hypercalcemia on routine blood chemistry. Improvement in preoperative localization has been proposed as a way to decrease operative time and decrease morbidity and mortality. The purpose of this study was to retrospectively review the Guthrie Clinic experience of parathyroidectomy with and without preoperative localization. One hundred nineteen patients who presented with primary hyperparathyroidism between 1983 and 1990 were evaluated. There were 27 males and 91 females with an average age of 61. Preoperative localization resulted in a significant decrease in operative time with preoperative localization decreasing operative time from 97 minutes without localization to 70 minutes with localization. Also, complications were less in patients undergoing preoperative localization (5.8% versus 13.9%). Preoperative localization was positively affected by gland size, with larger glands being easier to localized. In conclusion, accurate preoperative localization decreases operative time and decreases complications in this series of patients undergoing exploration for primary hyperparathyroidism. In our institution the thallium technitium scan is most accurate and is the localization procedure of choice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733541

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  2 in total

1.  Identification of pathologic parathyroid glands in patients with primary hyperparathyroidism.

Authors:  T Kobayashi; H Asakawa; Y Komoike; Y Nakano; Y Tamaki; M Monden
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.

Authors:  M Kebapci; E Entok; N Kebapci; B Adapinar
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.